US Stock MarketDetailed Quotes

INFIQ Infinity Pharmaceuticals

Watchlist
  • 0.000
  • +0.000+900.00%
15min DelayClose Mar 31 16:00 ET
907.61Market Cap0.00P/E (TTM)

About Infinity Pharmaceuticals Company

Infinity Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing novel medicines for people with cancer. It focuses on its drug development segment. The company was founded by Steven H. Holtzman and Matthew D. Shair on March 22, 1995 and is headquartered in Cambridge, MA.

Company Profile

SymbolINFIQ
Company NameInfinity Pharmaceuticals
Listing DateJul 27, 2000
Founded1995
CEOMr. Seth A. Tasker, J.D.
MarketPink Market
Employees30
Fiscal Year Ends12-31
Address1100 Massachusetts Avenue,4th Floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02138
Phone1-617-453-1000

Company Executives

  • Name
  • Position
  • Salary
  • Seth A. Tasker, J.D.
  • Chief Executive Officer
  • --
  • Adelene Q. Perkins
  • Chairman of the Board
  • --
  • Norman C. Selby
  • Lead Independent Director
  • --
  • David William Beier, J.D.
  • Independent Director
  • --
  • Dr. Richard B. Gaynor, M.D.
  • Independent Director
  • --
  • Dr. Anthony B. Evnin,PhD
  • Independent Director
  • --
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.